Skip to content

Home Search Authors Pakistan News Saved

SciRah

SciRah does not host or store research papers. Results come live from free, official scholarly APIs, and every paper links back to its original source.

Data sources

OpenAlex
Semantic Scholar
Crossref
CORE
arXiv
PubMed

Privacy policy Terms of service

D. Mendus · SciRah

Researcher profile · Semantic Scholar

D. Mendus

Share profile

D. Mendus — researcher profile on SciRah

h-index: 11
Works: 15
Citations: 985

Most-cited papers

Atezolizumab Plus Chemotherapy for First-Line Treatment of Non-Squamous Non-Small Cell Lung Cancer: Results From the Randomized Phase III IMpower132 Trial.
M. Nishio, F. Barlesi, H. West, S. Ball +16 more
2020Journal of Thoracic Oncology358 citations Open access
Semantic Scholar
Chronic cisplatin treatment promotes enhanced damage repair and tumor progression in a mouse model of lung cancer.
T. Oliver, Kim L. Mercer, L. Sayles, J. Burke +15 more
2010Genes & Development219 citations Open access
Semantic Scholar
OA05.07 IMpower132: PFS and Safety Results with 1L Atezolizumab + Carboplatin/Cisplatin + Pemetrexed in Stage IV Non-Squamous NSCLC
V. Papadimitrakopoulou, M. Cobo, R. Bordoni, P. Dubray-Longeras +15 more
2018Journal of Thoracic Oncology137 citations Open access
Semantic Scholar
Anti-TIGIT Antibody Tiragolumab Alone or With Atezolizumab in Patients With Advanced Solid Tumors
Tae Won Kim, Philippe Bédard, P. Lorusso, M. Gordon +20 more
2023JAMA Oncology73 citations Open access
Semantic Scholar
IMpower132: Efficacy of atezolizumab (atezo) + carboplatin (carbo)/cisplatin (cis) + pemetrexed (pem) as 1L treatment in key subgroups with stage IV non-squamous non-small cell lung cancer (NSCLC).
F. Barlesi, M. Nishio, M. Cobo, Nicola Steele +16 more
2018Annals of Oncology49 citations Open access
Semantic Scholar
Fast progression in patients treated with a checkpoint inhibitor (cpi) vs chemotherapy in OAK, a phase III trial of atezolizumab (atezo) vs docetaxel (doc) in 2L+ NSCLC
D. Gandara, M. Reck, S. Morris, A. Cardona +3 more
2018Annals of Oncology32 citations Open access
Semantic Scholar
Thrombospondins 1 and 2 are important for afferent synapse formation and function in the inner ear
D. Mendus, Srividya Sundaresan, N. Grillet, Felix Wangsawihardja +4 more
2014European Journal of Neuroscience24 citations Open access
Semantic Scholar
Fast progression in non–small cell lung cancer: results from the randomized phase III OAK study evaluating second-line atezolizumab versus docetaxel
D. Gandara, M. Reck, D. Moro-Sibilot, J. Mazières +7 more
2021Journal for ImmunoTherapy of Cancer23 citations Open access
Semantic Scholar
LBA2 Updated analysis and patient-reported outcomes (PROs) from CITYSCAPE: A randomised, double-blind, phase II study of the anti-TIGIT antibody tiragolumab + atezolizumab (TA) versus placebo + atezolizumab (PA) as first-line treatment for PD-L1+ NSCLC
B. Cho, D. Rodríguez-Abreu, M. Hussein, M. Cobo +15 more
2021Annals of Oncology21 citations Open access
Semantic Scholar
LBA-5 Phase Ib study of the anti-TIGIT antibody tiragolumab in combination with atezolizumab in patients with metastatic esophageal cancer
Z. Wainberg, I. Matos, J. Delord, P. Cassier +16 more
2021Annals of Oncology18 citations Open access
Semantic Scholar
A Lack of Immune System Genes Causes Loss in High Frequency Hearing but Does Not Disrupt Cochlear Synapse Maturation in Mice
M. Calton, Dasom Lee, Srividya Sundaresan, D. Mendus +4 more
2014PLoS ONE13 citations Open access
Semantic Scholar
375O Final efficacy results from IMpower132: First-line atezolizumab + chemotherapy in patients with stage IV non-squamous NSCLC
M. Nishio, F. Barlesi, S. Ball, R. Bordoni +15 more
202010 citations Open access
Semantic Scholar
Diphenhydramine increases the therapeutic window for platinum drugs by simultaneously sensitizing tumor cells and protecting normal cells
Margarita Melnikova, Ulrike Sophie Wauer, D. Mendus, R. Hilger +10 more
2020Molecular Oncology10 citations Open access
Semantic Scholar
Response to Letter to the Editor.
M. Nishio, D. Mendus, Lijia Wang, M. Socinski
2021Journal of Thoracic Oncology0 citations Open access
Semantic Scholar
tumor progression in a mouse model of lung cancer Chronic cisplatin treatment promotes enhanced damage repair and Material
T. Oliver, Kim L. Mercer, L. Sayles, J. Burke +15 more
20100 citations
Semantic Scholar

Frequent co-authors

Invite them to SciRah by sharing their profile.

M. Nishio×5
Invite
M. Nishio — researcher profile on SciRah
X. Wen×5
Invite
X. Wen — researcher profile on SciRah
T. Hoang×4
Invite
T. Hoang — researcher profile on SciRah
S. Ball×3
Invite
S. Ball — researcher profile on SciRah

×3

Invite

R. Bordoni — researcher profile on SciRah

Invite

M. Cobo — researcher profile on SciRah

J. Goldschmidt×3

Invite

J. Goldschmidt — researcher profile on SciRah

Invite

S. Novello — researcher profile on SciRah

Invite

F. Orlandi — researcher profile on SciRah

Invite

R. Sanborn — researcher profile on SciRah

Invite

Z. Szalai — researcher profile on SciRah

Invite

G. Ursol — researcher profile on SciRah